Stem cells, the flu pandemic and rising carbon dioxide levels

This week Diana Garnham, CEO of the Science Council joins Clive and FT pharmaceuticals correspondent Andrew Jack, in the studio.

Topics covered include the controversial use of embryonic stem cells. We hear from three different companies using these cells in different ways, with one of them using them to stimulate hair growth.

Andrew reports back on his recent visit to the World Health Organisation in Geneva.

Science Magazine reports on how future food security is threatened by rising carbon dioxide levels.

Bill Caldwell, chief executive of the company Advanced Cell Technology
Bob Palay, chief executive of the iPSC company Cellular Dynamics
Gail Naughton, chief executive of the company Histogen

Next week
Something very exciting which we are not allowed to breathe a word of until then.

Produced by LJ Filotrani